Piper Sandler Companies is an investment bank and institutional securities firm serving corporations, private equity groups, public entities, non-profit entities, and institutional investors in the United States and internationally. The company is headquartered in Minneapolis, Minnesota.
| Revenue (TTM) | $2.02B |
| Gross Profit (TTM) | $1.84B |
| EBITDA | — |
| Operating Margin | 21.80% |
| Return on Equity | 22.20% |
| Return on Assets | 16.50% |
| Revenue/Share (TTM) | $30.00 |
| Book Value | $19.77 |
| Price-to-Book | 3.67 |
| Price-to-Sales (TTM) | 2.52 |
| EV/Revenue | 2.581 |
| EV/EBITDA | — |
| Quarterly Earnings Growth (YoY) | 1.10% |
| Quarterly Revenue Growth (YoY) | 32.80% |
| Shares Outstanding | $67.58M |
| Float | $68.80M |
| % Insiders | 2.60% |
| % Institutions | 87.41% |
Volatility is currently expanding
Investors interested in stocks from the Financial - Miscellaneous Services sector have probably already heard of Piper Sandler Companies (PIPR) and Moody's (MCO). But which of these two companies is the best option for those looking for undervalued stocks?
NEW YORK--(BUSINESS WIRE)--Piper Sandler Companies (NYSE: PIPR), a leading investment bank, is pleased to announce the addition of John D'Amico as a managing director in the Piper Sandler restructuring group. D'Amico will be focused on advising a broad range of clients in complex restructurings and special situation transactions.With approximately 25 years of investment banking and corporate advisory experience, D'Amico has advised companies, boards of directors, official and ad hoc creditor com.
Investors interested in Financial - Miscellaneous Services stocks are likely familiar with Orix (IX) and Piper Sandler Companies (PIPR). But which of these two stocks is more attractive to value investors?
Financing led by Piper Sandler Merchant Banking, with participation from new investors Johnson & Johnson Innovation – JJDC, Inc., Johnson & Johnson's corporate venture capital arm, and Medtronic Participation by existing investors, including Bain Capital Life Sciences and Perceptive Xontogeny Venture Funds Proceeds will support the conclusion of the STRIDE pivotal trial, continued operational scale-up, advancement of regulatory work toward a future Premarket Approval (PMA) submission to the FDA, and preparations for US commercialization Board strengthened with addition of Kevin Conroy as Lead Independent Director, Christopher Geyen as Chair of the Audit Committee, and Tom Schnettler representing Series C investors BOSTON, June 4, 2026 /PRNewswire/ -- CereVasc, Inc., a clinical-stage medical device company developing novel, minimally invasive treatments for neurological diseases, today announced it has successfully completed the initial closing of an $85 million Series C financing. Piper Sandler Merchant Banking led the financing with participation from Johnson & Johnson Innovation – JJDC, Inc., Johnson & Johnson's corporate venture capital arm, and Medtronic, along with existing investors Bain Capital Life Sciences and Perceptive Xontogeny Venture Funds.
Piper Sandler NYSE: PIPR posted its best first quarter ever on May 7, with 33% revenue growth and record investment banking. It was the 10th consecutive quarter of year-over-year growth.
NEW YORK--(BUSINESS WIRE)--Piper Sandler Companies (NYSE: PIPR), a leading investment bank, is pleased to announce the additions of John Mori and Eric Friel as managing directors to lead a new group that will focus on distressed debt and special assets. Mori will be based in Greenwich and Friel will be in New York, both reporting to Michael Piper, head of fixed income at Piper Sandler. The distressed debt and special asset group will source and trade specialized credit products, including distr.
Wall Street delivered a split verdict on Uber Technologies (NYSE:UBER | UBER Price Prediction) following the company's Q1 2026 earnings report on May 6.
FDS and peers lift dividends as volatile markets and inflation fears push investors toward steady income plays backed by solid fundamentals.
Piper Sandler Companies (PIPR) Q1 2026 Earnings Call Transcript
Piper Sandler Companies (PIPR) came out with quarterly earnings of $1 per share, beating the Zacks Consensus Estimate of $0.85 per share. This compares to earnings of $1.02 per share a year ago.
